Abstract
Predictive Markers of High-Grade or Serious Treatment-Emergent Infections with Daratumumab-Based Regimens in Newly Diagnosed Multiple Myeloma (NDMM)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have